Groups (IADPSG) criteria for gestational diabetes mellitus (GDM) in Australia has been controversial. Obesity in pregnancy is also a growing concern.
INTRODUCTION
The Australasian Diabetes in Pregnancy Society (ADIPS) criteria for the diagnosis of gestational diabetes mellitus (GDM) was initially modified from the WHO criteria in 1991, and agreed to by consensus in 1998. 1 In 2013, ADIPS and subsequently RANZCOG adopted the International Association of Diabetes Study Groups (IADPSG) criteria for GDM. 2, 3 The IADPSG oral glucose tolerance test (OGTT) thresholds for diagnosis had also been arrived at by consensus, chosen on the basis of a 1.75 times odds ratio risk relative to the mean, for the core pregnancy outcomes of the Hyperglycaemia Adverse Pregnancy Outcomes (HAPO)
Study. 4 Concerns regarding the IADPSG criteria include the observational nature of the HAPO Study, the lack of randomised controlled trials using these criteria, the increase in diagnosis rate, workload and resources required, and the questionable significance of some of the primary outcomes. 5, 6 The WHO has supported the IADPSG criteria, but states that the quality of the evidence is very low and that the strength of the recommendation is weak. 7 The US National Institutes of Health stated that 'the panel is particularly concerned about the adoption of new criteria that would increase the prevalence of GDM, and the corresponding costs and interventions, without clear demonstration of improvements in the most clinically important health and patient-centered outcomes'.
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Australian studies have suggested that the change in criteria would result in little change, or would increase the diagnosis of GDM by up to 50%. [9] [10] [11] [12] [13] Studies projecting a minimal or smaller increase have mostly based their analyses on data from the era when OGTTs with a fasting and two-hour level were performed only if the results of a screening 50 g non-fasting glucose challenge test was elevated; thus they underestimate the true increase in diagnosis rate. There are two published studies where
OGTTs with fasting, one-and two-hour samples were routinely performed, from which the true change in incidence could be assessed. One from Western Australia found an increase in GDM from 13% to 16% with application of the IADPSG criteria, 12 and the second study, from NSW, found that the incidence of GDM would double from 14.8% to 29.6%.
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We are also concerned about the dramatic increase in obesity which is now a major concern for antenatal care. Obesity is strongly associated with GDM, and is also predictive of adverse pregnancy outcomes. 14 Its relationship with the IADPSG criteria has not been well studied.
Our hospital has moved to universal testing with OGTTs including fasting, one-and two-hour samples, but retained the ADIPS1998 criteria for the diagnosis of GDM. This has given us an opportunity to compare the diagnosis of GDM by each criterion, and also examine pregnancy outcomes of untreated women who are obese, or would be diagnosed with GDM if we were to adopt the IADPSG criteria.
MATERIALS AND METHODS
We conducted a retrospective cohort study examining pregnancies from September 2014, when our hospital introduced universal testing for GDM with a 75 g OGTT, to September 2016.
These OGTTs were performed either in-house, or were out- with Maori or Polynesian names were designated as Polynesian.
There was no attempt to deduce ethnicity of women born in other countries.
Outcomes examined included gestational hypertension, preeclampsia, large-for-gestational age (LGA, defined as >90th birth centile), small-for-gestational age (SGA, defined as <10th birth centile), preterm delivery, primary caesarean section (PCS), induction of labour (IOL), shoulder dystocia (SD), admission to neonatal intensive care and perinatal death. Birth centiles were calculated using the validated customised gestation.net bulk centile calculator Australian version 6.7.8 which adjusts for maternal weight and height, parity, ethnicity, neonatal gender, gestation and birthweight. 15 Preterm birth was classified as delivery <37 weeks ges- 
Statistical analysis
Statistical analysis was performed using SPSS version 23 (IBM, Armonk, NY, USA). Significance was set at P-value < 0.05 using a had GDM on ADIPS1998 criteria only, and 723 (11.7%) had GDM satisfying both criteria. Thus, in 927 (15%) pregnancies, there was GDM by the ADIPS1998 criteria, and this would increase to 1098 (17.8%) if the IADPSG criteria were to be adopted.
Of the pregnancies in the IADPSG only group, 186 had an elevated fasting glucose only (5.1-5.4 mmol/L), 154 had an elevated one-hour result only (≥10 mmol/L) and 35 had both elevated fasting and one-hour results.
Compared to the ADIPS1998 only group, the IADPSG only cohort had a higher proportion of women who were obese and had a higher BMI (Table 1 ). There was a higher proportion of women born in Australian/NZ, and fewer women from Asia.
The relationship between obesity, ethnic grouping and the diagnosis of GDM by the two different criteria were explored by logistic regression, with adjustment for maternal age, parity and smoking ( Table 2) . Obesity was independently associated with both the diagnosis of GDM by the IADPSG criteria (odds ratio Women in the untreated IADPSG only cohort had an increased risk of gestational hypertension, pre-eclampsia, IOL, PCS and LGA (P < 0.05) compared to controls (Table 3) . Their offspring also had higher birthweight and birth centiles (P < 0.05). Compared to women in the treated ADIPS1998 only cohort, untreated IADPSG only women had a higher risk of pre-eclampsia, SD, PCS and LGA (P < 0.05). Outcomes in the treated ADIPS GDM only group were similar to women who did not have GDM.
Further analysis of the 5248 pregnancies not treated for GDM was conducted to compare the potential impact of obesity against the adoption of the IADPSG criteria (Table 4) . Compared to women with normal BMI, obese women had an increased risk of pre-eclampsia, IOL, SD, PCS and SGA (P < 0.05) but not LGA.
Because of the unexpectedly high incidence of SGA, we also reanalysed this by removing maternal weight from the birth centile calculator. This resulted in a change in the calculated distribution of SGA, decreasing from 25% with underweight mothers, to 16.2%
with normal weight mothers, 12.5% with overweight mothers and 10.7% with obese mothers (P < 0.001).
Multivariate analysis was conducted to examine the relative importance of GDM by IADPSG criteria and obesity in the devel- 
DISCUSSION
We have found that in our population, a switch from the ADIPS1998 to the IADPSG criteria would increase the number of women with GDM by 2.7%, a modest increase compared to an adjoining local health district (LHD) of Sydney, where a change in criteria would result in a doubling in the incidence of GDM. 13 It is likely that the demographics of the LHDs contribute to the differences in incidence of GDM between the two studies. Our LHD has higher numbers of women from an Asian background, and fewer who were obese. Interestingly our increase is almost the same as that found in a Western Australian study, 12 yet in that study, there
were smaller numbers of women from an Asian background. A key finding of our study is that a change to the IADPSG criteria would result in the reduction in the percentage of Asian women being diagnosed with GDM, but an increase in overweight and obese women with GDM. Our analysis indicates that Asian ethnicity is more strongly associated with GDM diagnosed by ADIPS1998 criteria than by IADPSG criteria.
Untreated women in the IADPSG only group generally had worse outcomes than women who did not have GDM. This is expected as these women had higher fasting glucose levels and concords with the continuum of risk in the HAPO Study. 4 These women also generally had worse outcomes than treated women with GDM diagnosed by ADIPS1998 criteria. However, there is little evidence in the literature that treatment would improve their outcomes. In both large randomised controlled trials which showed benefit treating GDM, inclusion was based on elevated glucose levels after a glucose load rather than fasting levels. In the American study, women were only eligible if they failed a 50 g glucose challenge test (thus excluding women with only elevated fasting glucose levels), and then those with a fasting glucose ≥5.3 mmol/L on the subsequent 100 g OGTT were also excluded. 16 In the Australian study, women were identified as GDM if they had a two-hour glucose ≥7.8 mmol/L, with the fasting result not being part of the entry criteria. 17 As the majority of women in our IADPSG only cohort were diagnosed on the basis of the fasting glucose level, they would not have met the inclusion criteria for these trials and we are unable to conclude that glycaemic treatment would improve their outcomes.
With the stronger association between obesity and pregnancy complications seen in our study, one could argue it may be more appropriate to invest our stretched resources into the management of obesity, rather than the IADPSG only group.
Indeed, in the HAPO Study, there was a stronger association between adverse pregnancy outcomes and BMI than for glycaemia. 14 The management of obesity in pregnancy has attracted insufficient attention in Australia, with greater focus on glucose control. Perhaps this is because it is easier to treat hyperglycaemia. While a large Australian randomised controlled trial failed to demonstrate better pregnancy outcomes with lifestyle management of obesity, 18 a meta-analysis has shown that some lifestyle intervention programs can reduce maternal gestational weight gain with improvement in some pregnancy outcomes. 19 Therefore, we should not regard obesity management in pregnancy as futile or too difficult, although its cost-effectiveness remains to be determined.
The increased incidence of SGA among the obese women was surprising, as obesity is typically associated with LGA. 20 It is possible that this was a consequence of excessive dietary restriction, as obese women are encouraged to limit weight gain.
There are data that weight gain below guidelines is associated with increased SGA. 21 This raises concerns, as it suggests we may be over-restricting dietary intake in women perceived to be at risk of LGA. Similarly there was a trend to greater SGA among the treated GDM groups; might we also increase the incidence of SGA among the women in the IADPSG only group through dietary restriction if we treat them for GDM? The different distribution of SGA when excluding maternal weight from the birth centile calculator highlights the importance of methodology in the determination of this outcome. SGA determined by customised birth centile calculators correlates better with adverse perinatal outcomes in some studies, 22, 23 and this has been shown specifically for obese women. 24 While their usefulness has been debated, 25 their use is routinely recommended in the UK.
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A limitation of our study is that we are unable to verify our concerns regarding dietary restriction with gestational weight gain data. Another limitation is the reliance on the Obstetrix database for pregnancy outcomes, but a validation study of the NSW Midwives Data Collection (into which data from Obstetrix is extracted) had previously found this to have >93% agreement across all variables. 27 In summary, we have conducted one of the first Australian studies to compare the incidence of GDM diagnosed by ADIPS1998 or IADPSG criteria, where all women had an OGTT with fasting, one-and two-hour samples, and the largest with pregnancy outcomes. We were able to examine pregnancy outcomes for untreated women who had GDM by IADPSG but not ADIPS1998 criteria. We were also able to compare the impact of obesity against that of GDM by IADPSG criteria in the untreated cohort.
We have found that a change from the ADIPS1998 to the IADPSG criteria would result in an increase in the diagnosis of GDM. The additional women are at higher risk, but there is little evidence in the literature that treatment would improve their pregnancy outcomes. Obesity is associated with an even greater risk yet there are no standardised or systematic interventions for the management of obesity in pregnancy in Australia. A focus on healthy eating for appropriate weight gain in pregnancy is important to avoid both LGA and SGA. These issues should not be ignored in the glucocentric debate around the change in the diagnostic criteria for GDM. LGA, large for gestational age; SGA, small for gestational age.
